Formulators of parenteral drugs must be cautious of specific considerations and challenges that arise during development and manufacture. As the numbers of poorly soluble and complex molecules, such ...

Investing in formulation strategies earlier on in development will maximize the chance of success. The bio/pharmaceutical industry is under more pressure than other industries to create innovative ...

The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

Zanubrutinib's new tablet formulation is approved for all five indications, reinforcing its market leadership among BTK inhibitors. The 160 mg tablet simplifies dosing, reducing the daily intake from ...

Lipid nanoparticle formulation has increased over the past two decades. LNPs have proven to be effective nano-based delivery vehicles for cytotoxic chemotherapeutic drugs, nucleic acid therapies and ...

Texicryl alkali swellable emulsions (ASEs) are dispersions of acid-functional acrylic polymers in water. These emulsions are supplied at low pH, meaning that acid groups on the polymer chains must be ...

The FDA approved an oral suspension formulation of Imbruvica, aiding patients with swallowing difficulties across all its indications, including CLL, SLL, Waldenström’s macroglobulinemia, and cGVHD.

Livestock production and consumption of animal products are crucial to the economic and nutritional well-being of millions of people around the world. Animal feed plays a leading role in the food ...